SCHEMBL7232128

SCHEMBL7232128

CCCC(C=O)NC(=O)c1cccnc1N1CCN(Cc2ccccc2)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAPN1 P07384 3/20 0.49
CTSS P25774 2/20 0.49
CHIA Q9BZP6 1/20 0.47
TSHR P16473 1/20 0.46
HSD17B10 Q99714 1/20 0.46
HTR3E A5X5Y0 2/20 0.45
HTR3B O95264 2/20 0.45
HTR3A P46098 2/20 0.45
HTR3D Q70Z44 2/20 0.45
HTR3C Q8WXA8 2/20 0.45
HTR1A P08908 1/20 0.45
HTR2C P28335 1/20 0.45
HSD11B1 P28845 1/20 0.45
BCHE P06276 5/20 0.42
MAPT P10636 1/20 0.41
MAPK1 P28482 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CHRM4 P08173 1/20 0.41
HTR7 P34969 1/20 0.40
EPHX2 P34913 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7235830 0.89 CAPN1 (0.56) CAPN1CTSSCHIATSHRHSD17B10
SCHEMBL7238735 0.86 CAPN1 (0.53) CAPN1CTSSTSHRHSD17B10HTR3E
SCHEMBL7243415 0.85 CAPN1 (0.47) CAPN1CTSSCHIATSHRHSD17B10
SCHEMBL7238926 0.84 CAPN1 (0.49) CAPN1CTSSHSD17B10BCHEMAPT
SCHEMBL7235461 0.81 CAPN1 (0.47) CAPN1CTSSCHIATSHRHSD17B10
SCHEMBL7243236 0.81 L3MBTL1 (0.49) CAPN1CTSSTSHRHSD17B10MAPT
SCHEMBL7235428 0.81 CAPN1 (0.57) CAPN1CTSSTSHRHSD17B10
SCHEMBL7242743 0.81 TSHR (0.54) CAPN1CTSSCHIATSHRHSD17B10
SCHEMBL7242851 0.81 CHIA (0.58) CAPN1CTSSCHIATSHRHSD17B10
SCHEMBL7241450 0.80 CTSL (0.52) CAPN1CTSSTSHRBCHEMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6562827-B1 For the treatment of diseases in which increased calpain activity occurs such as neurodegenerative diseases or neuronal damage are caused by ischemia, trauma or mass hemorrhages ABBOTT LABORATORIES 2003-05-13 US disclosed